Frequently Asked Question:
The COVID-19 pandemic outbreak has increased the market for intravenous solutions. Globally, the Intensive Care Units (ICU) are inundated by the COVID-19 patients.
North America accounted for the most heightened share in the global intravenous solutions market.
The rise in the incidence of gastrointestinal illness and neurological ailments due to improper eating habits is a primary element driving the market’s growth rate.
The single dose amino acids segment had a major share in the global market in 2022.
The hospitals and clinics segment had a major share in the global market.